Klyx (Docusate Sodium, Sorbitol (E420))

Docusate sodium acts as a surfactant that reduces surface tension within the fecal mass, allowing water and fatty acids to penetrate and soften the stool. This makes the stool less dense and easier to evacuate. Sorbitol adds an osmotic effect, drawing additional water into the intestinal lumen to further aid passage.

The specific dose of Klyx is determined by the prescribing healthcare professional based on the patient’s age, condition severity, and response to therapy. The product is supplied as a rectal preparation and should be administered exactly as instructed on the label or by a qualified practitioner.

Safety data for Klyx in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made by a healthcare provider. Women who are pregnant or nursing should consult their doctor before using the product.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Klyx. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. The sales team then provides pricing, availability, shipping details and assists with any required import documentation.

Compared with stimulant laxatives, Klyx’s combination of docusate sodium and sorbitol works by softening stool and increasing water content rather than stimulating intestinal muscle contractions. This generally results in a gentler effect with fewer cramping episodes, making it suitable for patients who need mild to moderate relief without the harsher side‑effects associated with stimulant agents.

Klyx should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keeping the product in a dry, cool environment helps maintain its stability and effectiveness throughout its shelf life.

Klyx is administered rectally, typically as a suppository or enema, according to the instructions provided on the label or by a healthcare professional. The patient should lie on their side, insert the preparation gently into the rectum, and remain in that position for a few minutes to allow the product to act.

Although uncommon, serious adverse reactions can include severe abdominal pain, rectal bleeding, and allergic responses such as rash, swelling, or difficulty breathing. If any of these symptoms occur, the user should discontinue use immediately and seek medical attention. Prompt reporting of severe side effects helps ensure patient safety.

Klyx should be avoided in individuals with known hypersensitivity to docusate sodium, sorbitol, or any excipients in the formulation. It is also contraindicated in patients with intestinal obstruction, severe electrolyte imbalance, or acute abdominal conditions unless directed by a physician. Children should only use Klyx under medical supervision.